GlobeNewswire•1 hour agoGRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026GRI15.76%
ACCESS Newswire•8 hours agoVicore Pharma to Present at the European Respiratory Society Congress 2026VCRE8.72%